Summary
- Current Price
- As of today, AVBP price is $29.14, down -1.24% in the most recent trading session on
- Current Price All-Time High
- AVBP price is currently -19.89% below its historical high of $36.37 set on
- Market Cap
- AVBP current market cap is $1B, up +95.96% over the past 365 days
- PE Ratio
- AVBP PE ratio is unknown
- Revenue
- AVBP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AVBP is on
Profile
| Metric | Value |
|---|---|
| Full Name | ArriVent BioPharma, Inc. |
| Ticker | NASDAQ: AVBP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arrivent.com |
| Employees | 52 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $29.14 | |
| Price, 1D Change | -1.24% | |
| $1B | ||
| - | ||
| - | ||
| 1.17 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.32 | ||
| EPS, 1Y Change | -81.08% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.32 | ||
| EPS Estimate | N/A | -$3.76 |
| EPS Est. Change | N/A | +13.01% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $29.14 | |
| Price Target | - | $44.50 |
| Price Tgt. Change | - | +52.74% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.69 | -$2.39 | +11.33% | |
| -$4.28 | -$4.32 | -0.94% | |
| -$3.76 | N/A | +13.01% | |
| -$3.18 | N/A | +26.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $40.91M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $29.14 | |
| $21.99 | ||
| SMA 200 vs Price | -24.51% | |
| $26.26 | ||
| SMA 50 vs Price | -9.87% | |
| 1.17 | ||
| $1.65 | ||
| 55.86 | ||
| 34.28% | ||
| 55.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.32 | ||
| $0.00 | ||
| - | ||
| -$177.53M | ||
| - | ||
| -$166.31M | ||
| - | ||
| -$177.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 12.83 | ||
| 12.83 | ||
| - | ||
| - | ||
| 28.89 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.40 | ||
| -5.85 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $307.22M | ||
| $312.82M | ||
| $333.17M | ||
| $332.90M | ||
| $25.95M | ||
| $25.95M | ||
| $14.00K | ||
| $14.00K | ||
| $5.93M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $166.31M | ||
| $177.53M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$160.59M | ||
| -$71.23M | ||
| $203.06M | ||
| $0.00 | ||
| -$160.59M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| B. Riley Securities | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Cantor Fitzgerald | ||
| BTIG | ||
| Truist Securities | ||
| Citigroup | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with AVBP
FAQ
What is the ticker symbol for ArriVent BioPharma, Inc.?
The ticker symbol for ArriVent BioPharma, Inc. is NASDAQ:AVBP
Does ArriVent BioPharma, Inc. pay dividends?
No, ArriVent BioPharma, Inc. does not pay dividends
What sector is ArriVent BioPharma, Inc. in?
ArriVent BioPharma, Inc. is in the Healthcare sector
What industry is ArriVent BioPharma, Inc. in?
ArriVent BioPharma, Inc. is in the Biotechnology industry
What country is ArriVent BioPharma, Inc. based in?
ArriVent BioPharma, Inc. is headquartered in United States
When did ArriVent BioPharma, Inc. go public?
ArriVent BioPharma, Inc. initial public offering (IPO) was on January 26, 2024
Is ArriVent BioPharma, Inc. in the S&P 500?
No, ArriVent BioPharma, Inc. is not included in the S&P 500 index
Is ArriVent BioPharma, Inc. in the NASDAQ 100?
No, ArriVent BioPharma, Inc. is not included in the NASDAQ 100 index
Is ArriVent BioPharma, Inc. in the Dow Jones?
No, ArriVent BioPharma, Inc. is not included in the Dow Jones index
When was ArriVent BioPharma, Inc. last earnings report?
ArriVent BioPharma, Inc.'s most recent earnings report was on March 5, 2026
When does ArriVent BioPharma, Inc. report earnings?
The next expected earnings date for ArriVent BioPharma, Inc. is May 15, 2026
Data Sources & References
- AVBP Official Website arrivent.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1868279/000110465926024127/0001104659-26-024127-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1868279/000110465926024127/0001104659-26-024127-index.htm
- AVBP Profile on Yahoo Finance finance.yahoo.com/quote/AVBP
- AVBP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avbp